Scientists uncover a molecular weakness that could transform prostate cancer therapy. An international team of researchers has identified a new weakness in prostate cancer cells that could enhance ...
Phase 3 ARENSENS clinical trial results were presented at JADPRO 2025, indicating darolutamide plus ADT improved rPFS in prostate cancer.
This article was reviewed by Felix Gussone, MD. How Long Does Enclomiphene Stay in Your System? Testosterone plays a major ...
Androgen’s effects become more pronounced when there ... And if topical treatments fail, we look at whether hormone ...
This article was reviewed by Felix Gussone, MD. Low Testosterone and Joint Pain: What’s the Connection? Your knees, ankles, ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological ...
Colorado and over 20 other states have banned the practice aimed at changing the sexual orientation or gender identity of young people. Ann E. Marimow Reporting from Washington A central question for ...
WASHINGTON — A majority of Supreme Court justices on Tuesday seemed to lean in favor of a Colorado Christian counselor challenging bans on LGBTQ+ “conversion therapy” for kids as a violation of her ...
Supreme Court justices grilled lawyers for Colorado on Tuesday over the state’s argument that counselors giving talk therapy should be subject to the same medical regulations as doctors, banning ...
The U.S. Supreme Court on Oct. 7 is debating whether a Colorado ban on "conversion therapy" for gay and transgender minors violates a therapist's free speech, in other words, a fairly new ground for ...
Spruce Biosciences shares reached a 52-week high after a drug update and favorable comments on X by Martin Shkreli. Spruce said the Food and Drug Administration granted Breakthrough Therapy ...
The U.S. Food and Drug Administration is reviewing whether to change the warning label on hormone replacement therapy drugs used to treat menopause symptoms, a move many experts say is long overdue.